NerPharMa srl

NerPharMa Srl. offers a wide range of services which includes analytical services. Features: the QC labs are fully equipped with all the instruments needed to covers such as method development and validation; accelerated stressing test; ICH stability studies; dissolution profiles; materials compatibility; ...

NerPharMa Srl. offers a wide range of services which includes clinical supply management. Features: it is authorised and has wide experience in the manufacturing, labelling, packaging and distribution of investigational medicinal products from laboratory to production scale for Phase 1 to Phase 4 clinical ...

NerPharMa Srl. offers a wide range of services which includes dosage form development services. Features: it can support the development of sterile and oral solid dosage forms (conventional and nonconventional technologies), includes pre-formulation; formulation; process development; clinical supply; scale...

NerPharMa Srl. offers a wide range of services which includes manufacturing capabilities services. Features: it includes oral solid dose and semi-solid products- tablets by direct compression, wet and dry granulation processes; hard capsules filled with powders, tablets, liquids and semisolids. Sterile pro...

NerPharMa Srl. offers a wide range of services which includes regulatory assistance. Features: it offers to national and international partners, guidance and consulting in dossier preparation and filing. With particular experience in CMC section support for IND, NDA filings (EU, US, Japan); post filing/pos...

NerPharMa is a CDMO with a strong expertise in Oncology, bringing highly potent compounds, new products and unique innovative technologies to the market delivering a wide range of GMP services. NerPharMa owns a wide and cutting-edge organizational structure able to ensure the API full development and production (in NerPharMa DS division) and finished products (in NerPharMa DP division) intended for the world market, as well as the research and development of innovative formulation and delivery systems, operating in accordance with cGMP and are authorized by the most relevant authorities: AIFA, FDA, ANVISA Brazil, China FDA, PMDA Japan and Russia.

Globally recognized niche player in oncology DS development and manufacturing

Globally recognized niche CDMO and CMO player in sterile for chemotherapy
and innovative modalities